Table 3.
General health status, comorbidity, awareness of age-related change and prostate cancer-related quality-of-life of patients at follow-up after high-intensity focused ultrasound (HIFU)
| Parameter | Value |
|---|---|
| SF-12 health-related QoL | |
| General health rating | |
| Excellent/very good, (n, %) | 13 (27.1) |
| Good (n, %) | 28 (58.3) |
| Poor/very poor (n, %) | 5 (10.4) |
| Physical component score (mean, SD) | 48.3 (6.9) |
| Mental component score (mean, SD) | 53.1 (7.3) |
| No. of patients with physical component score > 50 (%) | 22 (45.8) |
| No. of patients with mental component score > 50 (%) | 36 (75) |
| Item missing (n, %) | 2 (4.2) |
| Charlson Comorbidity Index, % (mean, SD) | 29.8 (25.3) |
| Measures of subjective age (mean, SD) | |
| AARC-10 SF gainsa | 16.7 (3.3) |
| AARC-10 SF lossesa | 11.0 (3.3) |
| Discrepancy of felt and chronological age in years | − 10.4 (9.8) |
| Proportional discrepancy scoreb | − 0.14 (0.12) |
| Item missing (n, %) | 3 (6.3) |
| Clark’s prostate cancer-related QoL | |
| Health worry (mean, SD)c | 42.3 (22.6) |
| PSA concern (mean, SD)d | 88.0 (15.1) |
| Outlook (mean, SD)e | 51.6 (23.2) |
| Informed decision index (mean, SD)f | 88.7 (17.1) |
| Treatment regret index ≥ 40 (n, %)g | 10 (20.8) |
| Item missing (n, %) | 1 (2.1) |
AARC-10 SF awareness of age-related change short form, HIFU high-intensity focused ultrasound, SF-12 short form health survey, QoL quality of life
aHigher values indicate higher levels of perceived gains or losses
bHigher values indicate less discrepancy of felt and chronological age
cHigher values indicate greater worry
dHigher values indicate greater concern
eHigher values indicate better outlook
fHigher values indicate more informed decision
gValues ≥ 40 indicate regret